Meadow Creek Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$5.54M Buy
49,520
+224
+0.5% +$24.9K 0.11% 171
2019
Q2
$5.46M Buy
49,296
+3,232
+7% +$381K 0.11% 179
2019
Q1
$5.98M Buy
46,064
+18,352
+66% +$2.23M 0.12% 160
2018
Q4
$3.21M Buy
27,712
+5,440
+24% +$608K 0.07% 244
2018
Q3
$2.39M Sell
22,272
-656
-3% -$65.6K 0.05% 305
2018
Q2
$1.96M Buy
22,928
+1,728
+8% +$142K 0.04% 324
2018
Q1
$1.64M Sell
21,200
-2,992
-12% -$241K 0.04% 325
2017
Q4
$2.04M Buy
24,192
+6,384
+36% +$543K 0.04% 312
2017
Q3
$1.52M Sell
17,808
-1,664
-9% -$136K 0.04% 328
2017
Q2
$1.6M Sell
19,472
-1,472
-7% -$120K 0.04% 333
2017
Q1
$1.76M Sell
20,944
-12,368
-37% -$991K 0.04% 314
2016
Q4
$2.45M Buy
+33,312
New +$2.48M 0.06% 233

Other funds holding LLY

Meadow Creek Investment Management's LLY Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Eli Lilly (LLY) stake by 0.45% in Q3 2019, buying an estimated $24.9K and bringing the position to 49,520 shares worth $5.54M. The position accounts for 0.11% of the portfolio, ranked #171.

Meadow Creek Investment Management first reported a position in LLY in Q4 2016 and has held it in 12 quarters since. The position peaked at $5.98M in Q1 2019. 1,525 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • Meadow Creek Investment Management held 49,520 shares of Eli Lilly worth $5.54M as of Q3 2019.
  • Meadow Creek Investment Management bought 224 Eli Lilly shares in Q3 2019, an estimated $24.9K.
  • Eli Lilly made up 0.11% of Meadow Creek Investment Management's portfolio in Q3 2019, its #171 holding.
  • Meadow Creek Investment Management first reported a position in Eli Lilly in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Eli Lilly position peaked at $5.98M in Q1 2019.
  • 1,525 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.